Addressing the public health burden of respiratory viruses: the Battle against Respiratory Viruses (BRaVe) Initiative

Anaïs Legand, Sylvie Briand, Nikki Shindo, W. Abdullah Brooks, Menno D. De Jong, Jeremy Farrar, Ximena Aguilera, Frederick G. Hayden

Research output: Contribution to journalReview articlepeer-review

Abstract

Given the enormous estimated burden of respiratory virus infections worldwide, a substantial number of research priorities exist in order to better understand their epidemiology, pathogenesis, prevention and clinical management across different populations and resource settings. New therapeutics and specific vaccines for noninfluenza respiratory virus infections could provide enormous benefits in reducing the morbidity and mortality associated with these frequent infections and provide the foundation for responding to newly emerging threats. The BRaVe Initiative is a new WHO-led effort to catalyze multidisciplinary research on strategies to prevent and treat medically important respiratory virus infections with the goal of timely integration of scientific advances and technical innovations into public health practice.

Original languageEnglish (US)
Pages (from-to)953-968
Number of pages16
JournalFuture Virology
Volume8
Issue number10
DOIs
StatePublished - Oct 2013

Keywords

  • WHO research agenda
  • antivirals
  • emerging respiratory viruses
  • influenza virus
  • pneumonia
  • public health policies
  • respiratory syncytial virus
  • respiratory viral infections
  • severe acute respiratory infection
  • vaccines

ASJC Scopus subject areas

  • Virology

Fingerprint Dive into the research topics of 'Addressing the public health burden of respiratory viruses: the Battle against Respiratory Viruses (BRaVe) Initiative'. Together they form a unique fingerprint.

Cite this